Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
May 24, 2018
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

Consistent API Quality Calls for Collaboration

Best Practices for Shipping Single-Use Systems

Catalent to Develop Biosimilars for Valerius Biopharma


Top Stories

Lilly to Acquire AurKa Pharma in Deal Worth Up to $575 million

The acquisition of AurKa Pharma will help strength Eli Lilly’s oncology pipeline.
/ read more /


New “Right-to-Try” Law Challenges FDA Oversight

Right-to-Try bill has been sent to White House for President Trump’s signature after passage by Congress.
/ read more /

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe
advertisement

Industry News

IPEC-Americas Acquires Global Excipient Event

ExcipientFest has been acquired by IPEC and rebranded as Excipient World.
/ read more /


Apotex Recalls Product Due to Elevated Levels of Impurities

The company is recalling Piperacillin and Tazobactam for Injection, USP 3.375 Gram/Vial And 4.5 Gram/Vial strengths because of concerns of decreased potency due to elevated levels of impurities.
/ read more /


More Industry News

Supplier News

Catalent to Develop Biosimilars for Valerius Biopharma

Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
/ read more /


Cambrex Reports Expansions at its High Point, NC Facility

Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
/ read more /


More Supplier News
advertisement

Bio/Pharma News

FDA Approves First Preventive Treatment for Migraine

The agency approved Amgen and Novartis’ Aimovig (erenumab-aooe), the first FDA-approved preventive treatment for migraine in adults.
/ read more /

 

Gilead’s Kite Expands Cell Therapy Facilities in US, Europe

The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
/ read more /


More Bio/Pharma News
advertisement

Regulatory News

FDA Commissioner Puts Branded Companies on Notice

The FDA commissioner released a statement expressing the agency’s plan to address tactics used by pharma companies to delay generic-drug competition.
/ read more /

 

European and Indian Pharmacopoeias Coordinate on Quality Standards

Representatives from the two pharmacopeias held a symposium on European and Indian legislation and regulatory requirements regarding the quality of drugs.
/ read more /


More Regulatory News
advertisement

As the landscape continues to face an influx of regulations surrounding the reliability, consistency and accuracy of analytical methods and data, it is critical for the biopharmaceutical industry to adhere to new regulatory expectations.
Analytical Procedures & Methods Validation Europe provides a comprehensive understanding of regulatory trends and requirements, "hands-on" training for executing procedures that survive the lifecycle and solutions to challenges within the laboratory.
Learn more

FEATURED TOPICS

ANALYTICS

Reportable Values: Where is the Variation Coming From?

This article looks at a simple structured approach to assigning variance contributions and to assuring that the analytical procedure is fit for purpose.
/ read more /

OUTSOURCING

Consistent API Quality Calls for Collaboration

Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
/ read more /

advertisement

IVT's Stability Testing Europe allows attendees to review core FDA and ICH guidance to breaking down the latest regulatory policies, including a brand new updated WHO draft guidance for API and finished drug stability testing. Don't miss the chance to participate in hands-on training for small molecules, biologics and medical devices to harmonize global systems and enhance stability programmes.
Learn more


SUPPLY CHAIN

Best Practices for Shipping Single-Use Systems

Shipping biopharmaceuticals in single-use containers requires a thorough understanding of the distribution cycle and potential transportation risks.
/ read more /

QUALITY ASSURANCE/QUALITY CONTROL

The Statistical Evaluation of Cleaning Processes Using Process Capability and its Application to New Product Introduction

The approach presented in this study uses process capability index results to establish sampling strategies for use with new product cleaning and to efficiently reduce the risk of insufficient cleaning.
/ read more /


UPCOMING WEBCASTS

A Rational Approach to Excipient Selection
Wednesday, June 20, 2018 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Register now


E&L and Beyond: Qualifying Plastic Materials for Contaminants and Failure
North America: Tuesday, June 19, 2018 at 11am EDT | 10am CDT | 8am PDT
Europe: Tuesday, June 26, 2018 at 9am BST | 10am CEST
Register now


Continuous Processing in Biomanufacturing Considerations for Adoption and Case Studies in Biologic Development and Manufacturing
Thursday, June 14, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


How to Package Highly Complex Biologics
Wednesday, May 30, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


The Pharma Supply Chain Revolution
Thursday, May 24, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


ON DEMAND WEBCASTS

Improve Data Transparency and Collaboration Across your Manufacturing Network
On Demand
Learn more


Dose Design: Bridging Early- and Late-Phase Development
On Demand
Learn more


Events

BIO International Convention

June 4–7, 2018

Pharmaceutical-Nutraceutical Extrusion Seminar

June 6–7, 2018

American Biomanufacturing Summit 2018

June 14–15, 2018


more events

eBOOKS

Vaccines Development and Manufacturing 2017

Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.

contribute | contact editors | CONTACT SALES | subscribe | advertise